Otto Muzik1,2, Tom J Mangner3, William R Leonard4, Ajay Kumar3, James G Granneman5,6. 1. Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan otto@pet.wayne.edu. 2. Department of Radiology, Wayne State University School of Medicine, Detroit, Michigan. 3. Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan. 4. Department of Anthropology, Northwestern University, Evanston, Illinois. 5. Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan; and. 6. Center for Integrative Metabolic and Endocrine Research and Family Medicine.
Abstract
Recent work in rodents has demonstrated that basal activity of the local sympathetic nervous system is critical for maintaining brown adipocyte phenotypes in classic brown adipose tissue (BAT) and white adipose tissue (WAT). Accordingly, we sought to assess the relationship between sympathetic innervation and cold-induced activation of BAT and WAT in lean young adults. Methods: Twenty adult lean normal subjects (10 women and 10 men; mean age ± SD, 23.3 ± 3.8 y; body mass index, 23.7 ± 2.5 kg/m2) underwent 11C-meta-hydroxyephedrin (11C-HED) and 15O-water PET imaging at rest and after exposure to mild cold (16°C) temperature. In addition, 18F-FDG images were obtained during the cold stress condition to assess cold-activated BAT mass. Subjects were divided into 2 groups (high BAT and low BAT) based on the presence of 18F-FDG tracer uptake. Blood flow and 11C-HED retention index (RI, an indirect measure of sympathetic innervation) were calculated from dynamic PET scans at the location of BAT and WAT. Whole-body daily energy expenditure (DEE) during rest and cold stress was measured by indirect calorimetry. Tissue level oxygen consumption (MRO2) was determined and used to calculate the contribution of cold-activated BAT and WAT to daily DEE. Results: 18F-FDG uptake identified subjects with high and low levels of cold-activated BAT mass (high BAT, 96 ± 37 g; low-BAT, 16 ± 4 g). 11C-HED RI under thermoneutral conditions significantly predicted 18F-FDG uptake during cold stress (R2 = 0.68, P < 0.01). In contrast to the significant increase of 11C-HED RI during cold in BAT (2.42 ± 0.85 vs. 3.43 ± 0.93, P = 0.02), cold exposure decreased the 11C-HED RI in WAT (0.44 ± 0.22 vs. 0.41 ± 0.18) as a consequence of decreased perfusion (1.22 ± 0.20 vs. 1.12 ± 0.16 mL/100 g/min). The contribution of WAT to whole-body DEE was approximately 150 kcal/d at rest (149 ± 52 kcal/d), which decreased to approximately 100 kcal/d during cold (102 ± 47 kcal/d). Conclusion: The level of sympathetic innervation, as determined by 11C-HED RI, can predict levels of functional BAT. Overall, blood flow is the best independent predictor of 11C-HED RI and 18F-FDG uptake across thermoneutral and cold conditions. In contrast to BAT, cold stress reduces blood flow and 18F-FDG uptake in subcutaneous WAT, indicating that the physiologic response is to reduce heat loss rather than to generate heat.
Recent work in rodents has demonstrated that basal activity of the local sympathetic nervous system is critical for maintaining brown adipocyte phenotypes in classic brown adipose tissue (BAT) and white adipose tissue (WAT). Accordingly, we sought to assess the relationship between sympathetic innervation and cold-induced activation of BAT and WAT in lean young adults. Methods: Twenty adult lean normal subjects (10 women and 10 men; mean age ± SD, 23.3 ± 3.8 y; body mass index, 23.7 ± 2.5 kg/m2) underwent 11C-meta-hydroxyephedrin (11C-HED) and 15O-water PET imaging at rest and after exposure to mild cold (16°C) temperature. In addition, 18F-FDG images were obtained during the cold stress condition to assess cold-activated BAT mass. Subjects were divided into 2 groups (high BAT and low BAT) based on the presence of 18F-FDG tracer uptake. Blood flow and 11C-HED retention index (RI, an indirect measure of sympathetic innervation) were calculated from dynamic PET scans at the location of BAT and WAT. Whole-body daily energy expenditure (DEE) during rest and cold stress was measured by indirect calorimetry. Tissue level oxygen consumption (MRO2) was determined and used to calculate the contribution of cold-activated BAT and WAT to daily DEE. Results:18F-FDG uptake identified subjects with high and low levels of cold-activated BAT mass (high BAT, 96 ± 37 g; low-BAT, 16 ± 4 g). 11C-HED RI under thermoneutral conditions significantly predicted 18F-FDG uptake during cold stress (R2 = 0.68, P < 0.01). In contrast to the significant increase of 11C-HED RI during cold in BAT (2.42 ± 0.85 vs. 3.43 ± 0.93, P = 0.02), cold exposure decreased the 11C-HED RI in WAT (0.44 ± 0.22 vs. 0.41 ± 0.18) as a consequence of decreased perfusion (1.22 ± 0.20 vs. 1.12 ± 0.16 mL/100 g/min). The contribution of WAT to whole-body DEE was approximately 150 kcal/d at rest (149 ± 52 kcal/d), which decreased to approximately 100 kcal/d during cold (102 ± 47 kcal/d). Conclusion: The level of sympathetic innervation, as determined by 11C-HED RI, can predict levels of functional BAT. Overall, blood flow is the best independent predictor of 11C-HED RI and 18F-FDG uptake across thermoneutral and cold conditions. In contrast to BAT, cold stress reduces blood flow and 18F-FDG uptake in subcutaneous WAT, indicating that the physiologic response is to reduce heat loss rather than to generate heat.
Authors: Erik S Musiek; Yufen Chen; Marc Korczykowski; Babak Saboury; Patricia M Martinez; Janet S Reddin; Abass Alavi; Daniel Y Kimberg; David A Wolk; Per Julin; Andrew B Newberg; Steven E Arnold; John A Detre Journal: Alzheimers Dement Date: 2011-10-21 Impact factor: 21.566
Authors: Sander L J Wijers; Patrick Schrauwen; Marleen A van Baak; Wim H M Saris; Wouter D van Marken Lichtenbelt Journal: J Clin Endocrinol Metab Date: 2011-01-26 Impact factor: 5.958
Authors: G Andres Contreras; Yun-Hee Lee; Emilio P Mottillo; James G Granneman Journal: Am J Physiol Endocrinol Metab Date: 2014-09-02 Impact factor: 4.310
Authors: David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Aaron Charlop; Thomas J Lawton; Erin K Schubert; Jeffrey Tseng; Robert B Livingston Journal: J Nucl Med Date: 2002-04 Impact factor: 10.057
Authors: Otto Muzik; Thomas J Mangner; William R Leonard; Ajay Kumar; James Janisse; James G Granneman Journal: J Nucl Med Date: 2013-01-29 Impact factor: 10.057
Authors: Mueez U Din; Juho Raiko; Teemu Saari; Nobu Kudomi; Tuula Tolvanen; Vesa Oikonen; Jarmo Teuho; Hannu T Sipilä; Nina Savisto; Riitta Parkkola; Pirjo Nuutila; Kirsi A Virtanen Journal: Eur J Nucl Med Mol Imaging Date: 2016-03-19 Impact factor: 9.236
Authors: Brittany Begaye; Paolo Piaggi; Marie S Thearle; Kaitlyn Haskie; Mary Walter; Mathias Schlögl; Susan Bonfiglio; Jonathan Krakoff; Karyne L Vinales Journal: J Clin Endocrinol Metab Date: 2018-07-01 Impact factor: 5.958
Authors: Evanna L Mills; Cathal Harmon; Mark P Jedrychowski; Haopeng Xiao; Anja V Gruszczyk; Gary A Bradshaw; Nhien Tran; Ryan Garrity; Dina Laznik-Bogoslavski; John Szpyt; Hannah Prendeville; Lydia Lynch; Michael P Murphy; Steven P Gygi; Bruce M Spiegelman; Edward T Chouchani Journal: Cell Metab Date: 2021-12-02 Impact factor: 31.373
Authors: André C Carpentier; Denis P Blondin; Kirsi A Virtanen; Denis Richard; François Haman; Éric E Turcotte Journal: Front Endocrinol (Lausanne) Date: 2018-08-07 Impact factor: 5.555
Authors: Adilson Guilherme; David J Pedersen; Felipe Henriques; Alexander H Bedard; Elizabeth Henchey; Mark Kelly; Donald A Morgan; Kamal Rahmouni; Michael P Czech Journal: Mol Metab Date: 2018-06-27 Impact factor: 7.422